LORETTA SUE PARTON FNP-C NPI 1215445531

NPI Details

Loretta Sue Parton, FNP-C is a family nurse practitioner in Morristown, TN with 9 years of experience. Loretta Sue Parton, FNP-C NPI is 1215445531. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

2636 W ANDREW JOHNSON HWY
MORRISTOWN, TN
ZIP 37814-214
Phone: (423) 200-3225
Fax: (423) 200-3226

The NPI 1215445531 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Automated urinalysis test (HCPCS:81003)
• Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
• X-ray of chest, 2 views (HCPCS:71046)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)

The enumeration date for this NPI number is 1/22/2018 and was last updated on 7/30/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: